APGE
Apogee Therapeutics, Inc.
135.10$
+0.0%
vs. previous close
Closing price · As of: Sep 3, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.39 | -0.59 | -0.63 | -0.52 | -0.75 | -1.23 | -0.83 | -1.06 | -0.92 | -1.03 | -0.80 | -0.95 | -3.23 | |
| 0.00 | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | |
| 0.03 | 0.04 | 0.08 | 0.10 | 0.10 | 0.14 | 0.19 | 0.19 | 0.20 | 0.20 | 0.25 | 0.22 | 0.76 | |
| -0.01 | 0.05 | -0.03 | 0.03 | 0.07 | -0.11 | -0.05 | -0.12 | -0.01 | -0.08 | 0.02 | -0.12 | -0.17 | |
| 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.00 | 0.07 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -4.62 | -5.41 | -1.03 | -2.63 | -2.58 | 0.84 | 0.22 | 1.34 | 0.31 | -4.76 | -0.51 | -5.06 | -9.12 | |
| – | 0.00 | – | – | – | – | – | – | – | – | – | – | – | |
| 6.26 | 0.00 | 8.98 | 0.00 | 0.01 | 0.80 | 0.01 | 0.02 | 0.34 | 6.18 | 5.90 | 1.42 | 12.10 | |
| 1.25 | -1.38 | 7.32 | -3.15 | -3.32 | 0.42 | -0.60 | 0.30 | -0.28 | 0.39 | 4.60 | -4.59 | -0.25 | |
| -0.39 | -0.59 | -0.64 | -0.52 | -0.76 | -1.23 | -0.91 | -1.07 | -0.92 | -1.03 | -0.80 | -0.95 | -3.23 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.